Literature DB >> 22445484

BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair.

Samuel F Bunting1, Elsa Callén, Marina L Kozak, Jung Min Kim, Nancy Wong, Andrés J López-Contreras, Thomas Ludwig, Richard Baer, Robert B Faryabi, Amy Malhowski, Hua-Tang Chen, Oscar Fernandez-Capetillo, Alan D'Andrea, André Nussenzweig.   

Abstract

Brca1 is required for DNA repair by homologous recombination (HR) and normal embryonic development. Here we report that deletion of the DNA damage response factor 53BP1 overcomes embryonic lethality in Brca1-nullizygous mice and rescues HR deficiency, as measured by hypersensitivity to polyADP-ribose polymerase (PARP) inhibition. However, Brca1,53BP1 double-deficient cells are hypersensitive to DNA interstrand crosslinks (ICLs), indicating that BRCA1 has an additional role in DNA crosslink repair that is distinct from HR. Disruption of the nonhomologous end-joining (NHEJ) factor, Ku, promotes DNA repair in Brca1-deficient cells; however deletion of either Ku or 53BP1 exacerbates genomic instability in cells lacking FANCD2, a mediator of the Fanconi anemia pathway for ICL repair. BRCA1 therefore has two separate roles in ICL repair that can be modulated by manipulating NHEJ, whereas FANCD2 provides a key activity that cannot be bypassed by ablation of 53BP1 or Ku.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22445484      PMCID: PMC3340543          DOI: 10.1016/j.molcel.2012.02.015

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  56 in total

1.  Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells.

Authors:  A J Pierce; P Hu; M Han; N Ellis; M Jasin
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.

Authors:  Ronit I Yarden; Sherly Pardo-Reoyo; Magda Sgagias; Kenneth H Cowan; Lawrence C Brody
Journal:  Nat Genet       Date:  2002-02-11       Impact factor: 38.330

3.  BRCA1-independent ubiquitination of FANCD2.

Authors:  Cassandra J Vandenberg; Fanni Gergely; Chong Yi Ong; Paul Pace; Donna L Mallery; Kevin Hiom; Ketan J Patel
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

4.  Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

Authors:  X Xu; W Qiao; S P Linke; L Cao; W M Li; P A Furth; C C Harris; C X Deng
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

5.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

6.  53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.

Authors:  Samuel F Bunting; Elsa Callén; Nancy Wong; Hua-Tang Chen; Federica Polato; Amanda Gunn; Anne Bothmer; Niklas Feldhahn; Oscar Fernandez-Capetillo; Liu Cao; Xiaoling Xu; Chu-Xia Deng; Toren Finkel; Michel Nussenzweig; Jeremy M Stark; André Nussenzweig
Journal:  Cell       Date:  2010-04-01       Impact factor: 41.582

7.  The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin.

Authors:  A Bhattacharyya; U S Ear; B H Koller; R R Weichselbaum; D K Bishop
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

8.  p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.

Authors:  Irene M Ward; Kay Minn; Jan van Deursen; Junjie Chen
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Authors:  Scott Houghtaling; Cynthia Timmers; Meenakshi Noll; Milton J Finegold; Stephen N Jones; M Stephen Meyn; Markus Grompe
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

10.  BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.

Authors:  Q Ye; Y F Hu; H Zhong; A C Nye; A S Belmont; R Li
Journal:  J Cell Biol       Date:  2001-12-10       Impact factor: 10.539

View more
  143 in total

Review 1.  A tough row to hoe: when replication forks encounter DNA damage.

Authors:  Darshil R Patel; Robert S Weiss
Journal:  Biochem Soc Trans       Date:  2018-12-04       Impact factor: 5.407

Review 2.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

Review 3.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

Review 4.  The differences between ICL repair during and outside of S phase.

Authors:  Hannah L Williams; Max E Gottesman; Jean Gautier
Journal:  Trends Biochem Sci       Date:  2013-07-03       Impact factor: 13.807

Review 5.  Fanconi anaemia and the repair of Watson and Crick DNA crosslinks.

Authors:  Molly C Kottemann; Agata Smogorzewska
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

Review 6.  What is wrong with Fanconi anemia cells?

Authors:  Sharon B Cantor; Robert M Brosh
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Suppression of non-homologous end joining does not rescue DNA repair defects in Fanconi anemia patient cells.

Authors:  Supawat Thongthip; Brooke A Conti; Francis P Lach; Agata Smogorzewska
Journal:  Cell Cycle       Date:  2020-08-30       Impact factor: 4.534

8.  BRCA1: a missing link in the Fanconi anemia/BRCA pathway.

Authors:  Alan D D'Andrea
Journal:  Cancer Discov       Date:  2013-04       Impact factor: 39.397

9.  BRCA1 pathway function in basal-like breast cancer cells.

Authors:  Sarah J Hill; Allison P Clark; Daniel P Silver; David M Livingston
Journal:  Mol Cell Biol       Date:  2014-08-04       Impact factor: 4.272

10.  53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.

Authors:  Kathryn P Pennington; Anneka Wickramanayake; Barbara M Norquist; Christopher C Pennil; Rochelle L Garcia; Kathy J Agnew; Toshiyasu Taniguchi; Piri Welcsh; Elizabeth M Swisher
Journal:  Gynecol Oncol       Date:  2012-12-12       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.